Our previous study developed a qRT-PCR-based seven-gene microfluidic assay for NSCLC prognosis and prediction of chemotherapeutic benefits, including ABCC4, CCL19, SLC39A8, CD27, FUT7, DAG1, and ZNF71 [10]. The gene discussed is SLC39A8; the disease is non-small cell lung carcinoma.